NASDAQ:LFSC F/m Emerald Life Sciences Innovation ETF (LFSC) Price, Holdings, & News $22.52 +0.08 (+0.35%) As of 04/28/2025 03:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsTrendsBuy This Stock About F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LFSC alerts:Sign Up Key Stats Today's Range$22.36▼$22.6250-Day Range$19.11▼$25.7852-Week Range$18.78▼$27.76Volume5,487 shsAverage Volume3,537 shsMarket Capitalization$50.44 millionAssets Under Management$50.18 millionDividend YieldN/ANet Expense Ratio0.54%Aggregate RatingModerate Buy ETF OverviewThe F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.Read More… F/m Emerald Life Sciences Innovation ETF ExpensesTypeLFSCHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.57%0.56%0.53%0.53%Other Expenses-0.25%0.30%0.48%0.43%0.52%Total Expense0.54%0.70%0.72%0.68%0.71%Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%Net Expense0.54%0.61%0.63%0.62%0.60% Receive LFSC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for F/m Emerald Life Sciences Innovation ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address LFSC ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com LFSC ETF - Frequently Asked Questions How have LFSC shares performed this year? F/m Emerald Life Sciences Innovation ETF's stock was trading at $23.39 at the start of the year. Since then, LFSC shares have decreased by 3.7% and is now trading at $22.5190. View the best growth stocks for 2025 here. How do I buy shares of F/m Emerald Life Sciences Innovation ETF? Shares of LFSC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerF/m Investments Fund NameF/m Emerald Life Sciences Innovation ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:LFSC Inception Date10/30/2024 Fund ManagerJoseph Garner, Kenneth Mertz, Stacey Sears, Terry Smith, Nishit Trivedi WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$50.18 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorF/m Investments, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerMirae Asset Securities Miscellaneous Outstanding Shares2,240,000BetaN/A Creation Unit5,000 Creation Fee$300.00 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report Top 10 LFSC HoldingsBridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 7.62%Soleno Therapeutics (NASDAQ:SLNO)Holding Weight: 7.27%RadNet (NASDAQ:RDNT)Holding Weight: 6.99%Blueprint Medicines (NASDAQ:BPMC)Holding Weight: 6.10%Merit Medical Systems (NASDAQ:MMSI)Holding Weight: 5.78%LivaNova (NASDAQ:LIVN)Holding Weight: 4.80%TransMedics Group (NASDAQ:TMDX)Holding Weight: 4.65%Travere Therapeutics (NASDAQ:TVTX)Holding Weight: 4.54%Ultragenyx Pharmaceutical (NASDAQ:RARE)Holding Weight: 4.41%Collegium Pharmaceutical (NASDAQ:COLL)Holding Weight: 4.37%Full Holdings DetailsLFSC Sector ExposureLFSC Industry Exposure This page (NASDAQ:LFSC) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
